Wendy L Dixon's Net Worth

$10.7 Million

Estimate Recalculated Jul 17, 2024 07:02PM EST

Who is Wendy L Dixon?

Wendy L Dixon has an estimated net worth of $10.7 Million. This is based on reported shares across multiple companies, which include INCYTE CORP, BRISTOL MYERS SQUIBB CO, Orexigen Therapeutics, Inc., DENTSPLY INTERNATIONAL INC /DE/, Voyager Therapeutics, Inc., bluebird bio, Inc., ARVINAS, INC., Alkermes plc., Black Diamond Therapeutics, Inc., Sesen Bio, Inc., Furiex Pharmaceuticals, Inc., IOVANCE BIOTHERAPEUTICS, INC., ZEVRA THERAPEUTICS, INC., ALKERMES INC, and Ardea Biosciences, Inc./DE.

SEC CIK

Wendy L Dixon's CIK is 0001202283

Past Insider Trading and Trends

2008 was Wendy L Dixon's most active year for acquiring shares with 20 total transactions. Wendy L Dixon's most active month to acquire stocks was the month of May. 2021 was Wendy L Dixon's most active year for disposing of shares, totalling 21 transactions. Wendy L Dixon's most active month to dispose stocks was the month of October. 2021 saw Wendy L Dixon paying a total of $2,799,105.89 for 172,681 shares, this is the most they've acquired in one year. In 2019 Wendy L Dixon cashed out on 106,668 shares for a total of $4,475,773.82, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INCYTE CORP (INCY) Snapshot price: $57.6

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.42%
249
$79.42
$19,775.58
17.77K
Scheduled
Mar 31
Form 4
+1.51%
260
$73.40
$19,084.00
17.52K
Scheduled
Dec 31
Form 4
—
0
$47.65
$1,024,000.00
17.26K
Scheduled
Dec 23
Form 4
+1.43%
244
$68.78
$16,782.32
17.26K
Scheduled
Sep 30
Form 4
+1.27%
214
$84.13
$18,003.82
17.02K
Scheduled
Jun 30
Form 4
+12.93%
1.92K
—
—
16.8K
May 26
Form 4
+1.54%
225
$81.27
$18,285.75
14.88K
Scheduled
Mar 31
Form 4
+1.48%
213
$86.98
$18,526.74
14.65K
Scheduled
Dec 31
Form 4
+1.38%
197
$89.74
$17,678.78
14.44K
Scheduled
Sep 30
Form 4
—
0
$56.74
-$1,510,800.00
14.24K
Aug 27
Form 4
+1.29%
182
$103.97
$18,922.54
14.24K
Scheduled
Jun 30
Form 4
+10.03%
1.28K
—
—
14.06K
May 26
Form 4
+1.94%
243
$73.23
$17,794.89
12.78K
Scheduled
Mar 31
Form 4
+1.59%
196
$87.32
$17,114.72
12.54K
Scheduled
Dec 31
Form 4
—
0
$48.19
-$3,811,232.18
12.34K
Nov 6 - Nov 8
Form 4
+1.86%
225
$74.23
$16,701.75
12.34K
Scheduled
Sep 30
Form 4
+1.75%
208
$84.96
$17,671.68
12.12K
Scheduled
Jun 28
Form 4
+14.63%
1.52K
—
—
11.91K
Apr 26
Form 4
+1.84%
188
$86.01
$16,169.88
10.39K
Scheduled
Mar 29
Form 4
+2.56%
255
$63.59
$16,215.45
10.2K
Scheduled
Dec 31
Form 4
+2.42%
235
$69.08
$16,233.80
9.94K
Scheduled
Sep 28
Form 4
+2.56%
242
$67.00
$16,214.00
9.71K
Scheduled
Jun 29
Form 4
—
0
—
—
0
May 1
Form 4
+2.10%
195
$83.33
$16,249.35
9.47K
Scheduled
Mar 29
Form 4
+1.88%
171
$94.71
$16,195.41
9.27K
Scheduled
Dec 29
Form 4
+1.55%
139
$116.74
$16,226.86
9.1K
Scheduled
Sep 29
Form 4
+1.46%
129
$125.91
$16,242.39
8.96K
Scheduled
Jun 30
Form 4
—
0
—
—
0
May 26
Form 4
+1.39%
121
$133.67
$16,174.07
8.83K
Scheduled
Mar 31
Form 4
+1.89%
162
$100.27
$16,243.74
8.71K
Scheduled
Dec 30
Form 4
+2.05%
172
$94.29
$16,217.88
8.55K
Scheduled
Sep 30
Form 4
+2.48%
203
$79.98
$16,235.94
8.38K
Scheduled
Jun 30
Form 4
—
0
—
—
0
May 27
Form 4
+2.82%
224
$72.47
$16,233.28
8.18K
Scheduled
Mar 31
Form 4
+1.91%
149
$108.45
$16,159.05
7.95K
Scheduled
Dec 31
Form 4
+1.92%
147
$110.33
$16,218.51
7.8K
Scheduled
Oct 1
Form 4
+2.07%
155
$104.21
$16,152.55
7.66K
Scheduled
Jul 1
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
May 30
Form 4
—
0
—
—
0
May 30
Form 4
∞
7.5K
$13.40
$100,496.53
7.5K
Nov 17
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 21
Form 3
—
0
—
—
0
No matching records found

BRISTOL MYERS SQUIBB CO (BMY) Snapshot price: $48.635

CMO & Pres, Global Marketing

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.76%
-3.40K
$24.16
-$82,047.36
87K
May 22
Form 4
+15.98%
12.45K
$22.73
$283,079.42
90.4K
Mar 7
Form 4
-2.47%
-1.98K
$21.69
-$42,881.13
77.94K
Dec 2
Form 4
-4.69%
-3.94K
$25.64
-$100,919.04
79.92K
May 20
Form 4
+10.22%
7.78K
—
—
83.86K
Mar 1
Form 4
-1.90%
-1.48K
$24.06
-$35,512.56
76.08K
Dec 3
Form 4
+10.79%
7.56K
—
—
77.56K
Mar 2
Form 4
+16.67%
10K
—
—
70K
Sep 10
No matching records found

Orexigen Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 27
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
May 27
Form 4
—
0
—
—
0
Apr 20
Form 3
—
0
—
—
0
No matching records found

DENTSPLY INTERNATIONAL INC /DE/ (XRAY) Snapshot price: $33.68

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 8
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
May 11
Form 4
—
0
—
—
0
Apr 6
Form 4
—
0
—
—
0
Mar 24
Form 4
—
0
—
—
0
Jan 9
Form 4
—
0
—
—
0
Dec 18
Form 4
—
0
—
—
0
Oct 6
Form 4
—
0
—
—
0
Jul 7
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
May 12
Form 4
—
0
—
—
0
Apr 8
Form 4
—
0
—
—
0
Mar 18
Form 4
—
0
—
—
0
Jan 9
Form 4
—
0
—
—
0
Dec 17
Form 4
—
0
—
—
0
Oct 6 - Oct 7
Form 4
—
0
—
—
0
Jul 28
Form 4
—
0
—
—
0
Jul 1 - Jul 8
Form 4
—
0
—
—
0
Jun 24
Form 4
—
0
—
—
0
May 13
Form 4
—
0
—
—
0
Apr 7
Form 4/A
—
0
—
—
0
Mar 27
Form 4
—
0
—
—
0
Mar 27
Form 4
—
0
—
—
0
Jan 8
Form 4
—
0
—
—
0
Oct 9 - Dec 21
Form 4
—
0
—
—
0
Jul 31
Form 4
—
0
—
—
0
Jul 1
Form 3
—
0
—
—
0
No matching records found

Voyager Therapeutics, Inc. (VYGR) Snapshot price: $7.45

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 4
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 29
Form 4
—
0
—
—
0
Jan 3
Form 3
—
0
—
—
0
No matching records found